非酒精性脂肪性肝炎C57BL/6小鼠模型构建与评价
Construction and Evaluation of a Mouse Model of Nonalcoholic Steatohepatitis in C57BL/6 Mice
DOI: 10.12677/acm.2025.15123408, PDF,    科研立项经费支持
作者: 高丽晓, 郝乐天, 李佳晟, 张 娜*:包头医学院药学院,内蒙古 包头
关键词: 非酒精性脂肪肝炎MCDC57BL/6小鼠动物模型Nonalcoholic Steatohepatitis MCD C57BL/6 Mice Animal Model
摘要: 目的:采用MCD饲料喂养诱导小鼠非酒精性脂肪肝炎(NASH)模型,通过检测NASH相关指标来评价该模型的可行性。方法:将健康的C57BL/6小鼠采用随机分层方法将其分为对照组(饲养普通饲料,n = 6)和模型组(以MCD饲料干预,n = 6),于第6周末将其处死。取肝脏组织称重,观察其形态变化,比较体质量及肝脏质量;肝组织分别进行苏木精–伊红(HE)染色以评估组织病理变化;油红O染色以观察脂质情况;Masson染色以观察纤维化程度;联酶免疫吸附实验(ELISA)检测肝脏炎性因子(TNF-α、IL-6)表达,检测炎症水平。结果:与对照组相比,模型组小鼠肝组织表面暗淡无光,呈黄褐色,质地粗糙易碎且弹性差,体重显著降低(P < 0.0001),表明MCD诱导对小鼠的代谢状态产生了影响;通过HE染色观察,模型组小鼠肝细胞脂肪变性及炎性细胞浸润,表明MCD诱导能成功导致脂肪变性及肝细胞损伤;油红O染色显示,模型组小鼠肝组织出现大量红色脂滴,细胞内TG含量有所增加,表明MCD诱导能成功模拟肝细胞内脂质积聚;Masson染色显示模型组肝组织出现大范围蓝染胶原纤维,表明MCD诱导能成功导致轻度纤维化;模型组小鼠肝组织中TNF-α (P < 0.001)、IL-6 (P < 0.01)的含量均有所升高,表明MCD饲料成功诱导了炎症反应。结论:MCD饮食诱导下成功建立小鼠NASH模型。
Abstract: Objective: This study aimed to evaluate the feasibility of establishing a mouse model of non-alcoholic steatohepatitis (NASH) induced by a methionine-choline-deficient (MCD) diet through the detection of NASH-related indicators. Methods: Healthy C57BL/6 mice were randomly assigned to either a control group (fed a standard diet, n = 6) or a model group (fed an MCD diet, n = 6) using a stratified randomization method. At the end of the 6-week period, the mice were euthanized. Liver tissues were collected, weighed, and examined for morphological changes. Body weight and liver weight were compared between the two groups. Liver tissues were processed for hematoxylin-eosin (HE) staining to evaluate histopathological alterations, Oil Red O staining to visualize lipid accumulation, and Masson staining to assess the extent of fibrosis. Additionally, the expression levels of inflammatory cytokines (TNF-α and IL-6) in liver tissues were quantified using an enzyme-linked immunosorbent assay (ELISA) to determine the degree of inflammation. Results: Compared to the control group, the liver tissues of the model group mice appeared dull and yellowish-brown in color, with a rough, fragile texture and reduced elasticity. The body weight of the model group mice was significantly lower (P < 0.0001), indicating that the MCD diet affected the metabolic state of the mice. Histopathological examination using HE staining revealed hepatic steatosis and inflammatory cell infiltration in the liver tissues of the model group, demonstrating that the MCD diet successfully induced steatosis and hepatocyte injury. Oil Red O staining showed the presence of numerous red lipid droplets in the liver tissues of the model group, along with increased intracellular triglyceride (TG) content, indicating that the MCD diet effectively simulated lipid accumulation in hepatocytes. Masson staining revealed extensive blue-stained collagen fibers in the liver tissues of the model group, suggesting that the MCD diet successfully induced mild fibrosis. Furthermore, the levels of TNF-α (P < 0.001) and IL-6 (P < 0.01) in the liver tissues of the model group were significantly elevated, confirming that the MCD diet successfully triggered an inflammatory response. Conclusion: The NASH mouse model was successfully established through MCD diet induction.
文章引用:高丽晓, 郝乐天, 李佳晟, 张娜. 非酒精性脂肪性肝炎C57BL/6小鼠模型构建与评价[J]. 临床医学进展, 2025, 15(12): 279-286. https://doi.org/10.12677/acm.2025.15123408

参考文献

[1] Kolodziejczyk, A.A., Zheng, D., Shibolet, O. and Elinav, E. (2019) The Role of the Microbiome in NAFLD and NASH. EMBO Molecular Medicine, 11, Article No. 9302. [Google Scholar] [CrossRef] [PubMed]
[2] Guan, M., Wang, M., Liu, S., Ouyang, W., Liang, L., Pawlik, T.M., et al. (2021) Early Diagnosis and Therapeutic Strategies for Hepatocellular Carcinoma: From Bench to Bedside. World Journal of Gastrointestinal Oncology, 13, 197-215. [Google Scholar] [CrossRef] [PubMed]
[3] Morishita, A., Oura, K., Tadokoro, T., Fujita, K., Tani, J., Kobara, H., et al. (2023) MicroRNAs and Nonalcoholic Steatohepatitis: A Review. International Journal of Molecular Sciences, 24, Article 14482. [Google Scholar] [CrossRef] [PubMed]
[4] Povsic, M., Wong, O.Y., Perry, R. and Bottomley, J. (2019) A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH). Advances in Therapy, 36, 1574-1594. [Google Scholar] [CrossRef] [PubMed]
[5] Pinter, M., Pinato, D.J., Ramadori, P. and Heikenwalder, M. (2022) NASH and Hepatocellular Carcinoma: Immunology and Immunotherapy. Clinical Cancer Research, 29, 513-520. [Google Scholar] [CrossRef] [PubMed]
[6] Thomas, J.A., Kendall, B.J., Dalais, C., Macdonald, G.A. and Thrift, A.P. (2022) Hepatocellular and Extrahepatic Cancers in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. European Journal of Cancer, 173, 250-262. [Google Scholar] [CrossRef] [PubMed]
[7] Wattacheril, J., Issa, D. and Sanyal, A. (2018) Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies. Annual Review of Pharmacology and Toxicology, 58, 649-662. [Google Scholar] [CrossRef] [PubMed]
[8] Møllerhøj, M.B., Veidal, S.S., Thrane, K.T., Oró, D., Overgaard, A., Salinas, C.G., et al. (2022) Hepatoprotective Effects of Semaglutide, Lanifibranor and Dietary Intervention in the GAN Diet‐Induced Obese and Biopsy‐Confirmed Mouse Model of Nash. Clinical and Translational Science, 15, 1167-1186. [Google Scholar] [CrossRef] [PubMed]
[9] Rinella, M.E., Elias, M.S., Smolak, R.R., Fu, T., Borensztajn, J. and Green, R.M. (2008) Mechanisms of Hepatic Steatosis in Mice Fed a Lipogenic Methionine Choline-Deficient Diet. Journal of Lipid Research, 49, 1068-1076. [Google Scholar] [CrossRef] [PubMed]
[10] Caballero, F., Fernández, A., De Lacy, A.M., Fernández-Checa, J.C., Caballería, J. and García-Ruiz, C. (2009) Enhanced Free Cholesterol, SREBP-2 and Star Expression in Human Nash. Journal of Hepatology, 50, 789-796. [Google Scholar] [CrossRef] [PubMed]
[11] Feldstein, A.E. and Bailey, S.M. (2011) Emerging Role of Redox Dysregulation in Alcoholic and Nonalcoholic Fatty Liver Disease. Antioxidants & Redox Signaling, 15, 421-424. [Google Scholar] [CrossRef] [PubMed]
[12] Loomba, R., Friedman, S.L. and Shulman, G.I. (2021) Mechanisms and Disease Consequences of Nonalcoholic Fatty Liver Disease. Cell, 184, 2537-2564. [Google Scholar] [CrossRef] [PubMed]
[13] 黄樱硕, 魏巍, 佟小非, 等. 非酒精性脂肪性肝炎新药临床试验方案的系统评价[J]. 临床肝胆病杂志, 2022, 38(4): 798-804.
[14] Younossi, Z.M., Corey, K.E. and Lim, J.K. (2021) AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology, 160, 912-918. [Google Scholar] [CrossRef] [PubMed]
[15] Islam, M.S., Miao, L., Yu, H., Han, Z. and Sun, H. (2019) Ethanol Extract of Illicium Henryi Attenuates LPS-Induced Acute Kidney Injury in Mice via Regulating Inflammation and Oxidative Stress. Nutrients, 11, Article No. 1412. [Google Scholar] [CrossRef] [PubMed]
[16] Zhang, C., Sheng, J., Sarsaiya, S., Shu, F., Liu, T., Tu, X., et al. (2019) The Anti-Diabetic Activities, Gut Microbiota Composition, the Anti-Inflammatory Effects of Scutellaria-Coptis Herb Couple against Insulin Resistance-Model of Diabetes Involving the Toll-Like Receptor 4 Signaling Pathway. Journal of Ethnopharmacology, 237, 202-214. [Google Scholar] [CrossRef] [PubMed]
[17] 熊静平, 张跃新. 抑制脯氨酰内肽酶表达对非酒精性脂肪性肝炎小鼠模型的影响及作用机制[J]. 临床肝胆病杂志, 2025, 41(6): 1097-1104.
[18] 吴永保, 唐静, 闻治国, 等. 蛋氨酸对HepG2细胞和鸭原代肝细胞生长和脂质代谢的影响[J]. 动物营养学报, 2022, 34(8): 5364-5373.
[19] 杨海琳, 张定棋, 陈高峰, 等. 蛋氨酸-胆碱缺乏饮食诱导代谢相关脂肪肝模型小鼠血清和肝脏胆汁酸谱的变化[J]. 中国组织工程研究, 2021, 25(26): 4137-4144.